Dr. Fortin and her team thank the following grant agencies and programs for supporting their most recent research programs.
NIA NIH 1K08AG071985-01A1
May 2022- April 2027
Title: Small molecule inhibitors of hyperphosphorylated tau aggregation in Alzheimer's disease: lead optimization, and proof of concept in a rodent model
Role: Principal Investigator 
ASIP Summer Research Program
Summer 2022
 NIA NIH 1 R21 AG070447-01A1  
    September 2021-August 2023   
    Title:  Small molecule inhibitors of hyperphosphorylated tau aggregation and cytotoxicity for the development of Alzheimer’s therapeutics  
  Role: Principal Investigator 
PhRMA Research Starter Grant – Drug Discovery 
 September 2021-September 2022 
Title: Characterization of new inhibitors of p-tau aggregation and cytotoxicity 
Role: Principal Investigator
ASIP Summer Research Program 
 Summer 2020 
Winn Feline Foundation 
 August 2020-August 2022 
Title: In Vitro Characterization of Small Molecule Inhibitors of Pancreatic Amyloidosis for Diabetic Cats. 
Role: Principal Investigator
ACVIM Resident Research Grant Proposal, Pituitary Pars Intermedia Dysfunction project in horse 
 June 2019-January 2021 
Title: Pituitary Pars Intermedia Dysfunction (PPID): Is abnormal protein accumulation associated with degeneration of hypothalamic dopaminergic neurons? 
Role: Co-mentor 
Principal Investigator: Harold Schott
Learn more about how you can donate to support our lab's work.